Cargando…
Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism
BACKGROUND: Despite an improvement of prognosis in breast and colon cancer, the outcome of the metastatic disease is still severe. Microevolution of cancer cells often leads to drug resistance and tumor-recurrence. To target the driving forces of the tumor microevolution, we focused on synergistic d...
Autores principales: | Ruhnau, Jérôme, Parczyk, Jonas, Danker, Kerstin, Eickholt, Britta, Klein, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331156/ https://www.ncbi.nlm.nih.gov/pubmed/32615946 http://dx.doi.org/10.1186/s12885-020-07062-2 |
Ejemplares similares
-
Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines
por: Parczyk, Jonas, et al.
Publicado: (2021) -
Genome reorganization in different cancer types: detection of cancer specific breakpoint regions
por: Standfuß, Christoph, et al.
Publicado: (2019) -
Pharmacological interactions: Synergism, or not synergism, that is the question
por: Calzetta, Luigino, et al.
Publicado: (2021) -
Oxaliplatin and infliximab synergize to induce regression of colon cancer
por: Huang, Di, et al.
Publicado: (2018) -
Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
por: Laudonio, N., et al.
Publicado: (1990)